Axt IncAXTI

AXT Inc. (AXTI) kicked off 2026 with a $1.6M net loss on $26.9M revenue, a 12% drop from the same quarter in 2025, despite holding $107.1M in combined cash and short-term investments. The Fremont, California-based compound semiconductor wafer maker burned $11.7M in operating cash while increasing inventory to $90.2M, a $7.4M rise that outpaced its revenue decline.

AXTI’s core business revolves around gallium arsenide (GaAs) and indium phosphide (InP) substrates, critical for lasers, LEDs, and photonics. A July 8-K revealed a three-year supply deal with Coherent, where AXT committed to expanding Beijing facility capacity through 2028 in exchange for a prepayment. The agreement locks in wafer prices until the prepayment is exhausted, a move that stabilizes near-term cash flow but ties AXT to a single large customer’s demand rhythms.

Financials paint a company at a crossroads: diluted EPS of -$0.03 on 53.3M shares outstanding, $3.0M R&D spend, and $1.4M capex contrast with $274.9M equity and no debt. Yet the $7.4M inventory build-now 20% of total assets-raises questions about demand visibility. Meanwhile, the board added Jia-Bin Duh on July 16, a move announced via press release but not yet tied to strategic shifts.

Chart watchers have little to cling to: AXTI’s 52-week range isn’t disclosed in filings, and the stock’s 2026 performance isn’t addressed in supplied evidence. The lack of volume or price data in the source rail forces focus back on fundamentals, where inventory turns and Coherent’s prepayment utilization will matter more than technicals.

The evidence leaves gaps. Tongmei’s STAR Market application remains pending five years on, with no update in recent filings. The Coherent deal’s prepayment amount is undisclosed, as is Duh’s exact role on the board. The source requires readers to wait for 10-Qs to clarify whether the inventory build reflects strategic positioning or execution risk.